| Life Sciences & Nucleosides | Development and manufacturing of pharmaceutical intermediates and nucleoside analogs. | Strong technical expertise, quality certifications, and regulatory compliance support a competitive moat. | B2B clients in pharmaceuticals, primarily US and European companies. | Niche products with intellectual property and custom synthesis services. | 65 | 44 | Contract manufacturing and research services generating project-based revenues. | Contract-based pricing, project fees, and long-term supply agreements. | Innovative product pipeline, export demand, and backward integration to improve competitiveness. | |
| Specialty Chemicals | Custom synthesis and toll manufacturing of specialty chemicals for diverse applications. | Integrated manufacturing and strong scientific team enhance responsiveness and quality. | B2B industrial and specialty chemical companies in global markets. | Specialty intermediates catering to high-value niche markets. | 8 | 5 | Revenue from contract development and manufacturing services. | Fee-for-service and contract manufacturing agreements. | Export orientation and product customization drive segment growth. | |
| Contract Research Development and Manufacturing Operations (CRDMO) | Comprehensive services from custom research through commercial scale chemical manufacturing. | Integrated facility with 9 multipurpose plants and 50+ scientists offering end-to-end services. | Global pharmaceutical and specialty chemical corporations, B2B focused. | Value-added research and scale-up manufacturing projects. | 73 | 51 | Service fees and capacity utilization for contract and custom work. | Project-based and long-term manufacturing contracts. | Growing demand for outsourced chemical manufacturing and R&D support. | |
